[Technology and Achievements] Technology of Release Control Formulations (Sustained Release Granules)
By combining two types of enteric-coated granules, we achieve longer exposure! It has received high praise from clinical settings.
Our company has achieved a formulation that combines two types of enteric-coated pellets, one for immediate release (IR) and the other for delayed release (DDR), to attain a longer effective plasma concentration for clinical purposes. This technology is currently applied to capsule formulations sold domestically and has received high praise from clinical settings. We respond to all requests regarding CMC from the early stages of development to application. Please feel free to contact us when needed. 【Features】 ■ Achieves longer exposure by combining two types of enteric-coated pellets ■ Releases the active ingredient faster under neutral conditions than under acidic conditions, maintaining high plasma concentration ■ Applicable to oral morphine extended-release formulations *For more details, please refer to the PDF materials or feel free to contact us.
- Company:スペラファーマ
- Price:Other